Literature DB >> 8707498

Competing or complementary? Ethical considerations and the quality of randomized trials.

J Lumley1, H Bastian.   

Abstract

The ethical principles of beneficence (doing the best for one's patients and clients), nonmaleficence (doing no harm), autonomy, justice, and equity, are positively associated with the quality of a trial rather than being opposed to it. Ethical considerations involve such important questions as appropriate design and documentation, participation rates, withdrawals or losses to follow-up, careful monitoring of safety and efficacy, timely completion, generalizability, and publication and dissemination of findings. When conflicts between ethical considerations and the trial's scientific quality do occur, the ethical considerations must be paramount.

Entities:  

Mesh:

Year:  1996        PMID: 8707498     DOI: 10.1017/s0266462300009600

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

Review 1.  A review of treatment interventions in whiplash-associated disorders.

Authors:  Aris Seferiadis; Mark Rosenfeld; Ronny Gunnarsson
Journal:  Eur Spine J       Date:  2004-05-05       Impact factor: 3.134

Review 2.  Risk factors for subject withdrawals in clinical trials evaluating glaucoma medications.

Authors:  William C Stewart; Christina M Demos; Meredith K Turner; Jeanette A Stewart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-09       Impact factor: 3.117

3.  "Cold calling" in psychiatric follow up studies: is it justified?

Authors:  P Tyrer; H Seivewright; B Ferguson; T Johnson
Journal:  J Med Ethics       Date:  2003-08       Impact factor: 2.903

Review 4.  Methodological quality of a systematic review on physical therapy for temporomandibular disorders: influence of hand search and quality scales.

Authors:  Bart Craane; Pieter Ubele Dijkstra; Karel Stappaerts; Antoon De Laat
Journal:  Clin Oral Investig       Date:  2010-12-03       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.